Cresilon

Cresilon, Inc. develops, manufactures, and markets hemostatic medical devices using its proprietary hydrogel technology. The company's patented product, VETIGEL™, is a hemostatic gel made from plant-derived materials that stops bleeding within seconds. It acts as a clotting agent and also serves as a scaffold to promote skin growth. The company’s plant-based technology revolutionizes the current standard of care by stopping traumatic bleeding within seconds without the need for manual compression. The company’s current and future product lines target veterinary, human trauma, and human surgical applications.